NSE · SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
₹1,777.70+₹16.70 (+0.95%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 13.15% below the high.
Loading market information…
NSE · THYROCARE.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 10:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Thyrocare Technologies Limited’s quoted price sits in the lower half of its reported 52-week range, 31.25% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Thyrocare Technologies Limited’s forward annual dividend is ₹14.00 per share, paid semi-annual. The forward yield is 3.08% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Thyrocare Technologies Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Thyrocare Technologies Limited, an Indian enterprise, delivers a comprehensive array of diagnostic testing solutions to individual patients, medical laboratories, and healthcare providers throughout the nation. Its operations are structured across three main segments: Diagnostic Testing Services, Imaging Services, and other miscellaneous endeavors. The company's primary focus involves conducting numerous medical diagnostic analyses and specialized test panels aimed at the timely detection and effective management of various health conditions. These include, among others, disorders related to the thyroid, growth, metabolism, autoimmune responses, diabetes, anemia, cardiovascular health, infertility, COVID-19, and a broad spectrum of infectious diseases. Under its "Aarogyam" brand, Thyrocare offers 34 distinct profiles of tests, providing patients with extensive wellness and preventative health check-ups. Furthermore, the company sells "Sugarscan" branded glucometers and glucostrips, along with various consumable products and radiopharmaceuticals. Founded in 1996, Thyrocare Technologies Limited is headquartered in Navi Mumbai, India, and functions as a subsidiary of Docon Technologies Private Limited.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:00 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q4 2025 | Apr 23, 2025 | ₹2.10+31.25% vs estimate | ₹1.87B+1.44% vs estimate |
|---|
| Q3 2025 | Jan 23, 2025 | ₹1.20-14.29% vs estimate | ₹1.66B+0.45% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,777.70+₹16.70 (+0.95%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 13.15% below the high.
₹9,780.00+₹116.00 (+1.2%)
Divi's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 0.69% below the high.
₹4,613.40+₹33.40 (+0.73%)
Torrent Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 12.13% below the high.
₹1,907.20-₹4.50 (-0.24%)
Dr. Lal PathLabs Limited’s quoted price sits in the upper half of its reported 52-week range, 6.45% below the high.
₹1,466.50+₹2.30 (+0.16%)
Vijaya Diagnostic Centre Limited’s quoted price sits in the upper half of its reported 52-week range, 7.98% below the high.
₹546.90-₹6.95 (-1.25%)
Metropolis Healthcare Limited’s quoted price sits in the upper half of its reported 52-week range, 10.2% below the high.
₹485.60-₹34.20 (-6.58%)
Vimta Labs Limited’s quoted price sits in the lower half of its reported 52-week range, 33.93% below the high.
₹506.00+₹8.05 (+1.62%)
Krsnaa Diagnostics Limited’s quoted price sits in the lower half of its reported 52-week range, 39.62% below the high.
